BeStock  
Stocks › Medical Devices › LMRI

Lumexa Imaging LMRI

US equityMarket cap rank #3228Medical Devices
$10.59 −$0.12 (-1.12%)
Pre-market · Oct 8, 9:00 am ET · After hours $10.59 0.00%
Open$10.57
Prev close$10.71
Day range$10.49 – $10.71
Volume164.0K
Market cap$1.02B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$264.16M+5.1% YoY
Operating profit$4.40M-60.6% YoY
Net profit$2.75M+138.0% YoY
Diluted EPS$0.03+139.3% YoY
Free cash flow$22.53M+991.2% YoY
Operating cash flow$32.80M

Revenue, last 7 quarters

$248.0MDec '24$245.0MMar '25$251.4MJun '25$258.9MSep '25$267.7MDec '25$252.5MMar '26$264.2MJun '26

Net profit, last 7 quarters

$-25.1MDec '24$-7.7MMar '25$-7.2MJun '25$-3.5MSep '25$-28.7MDec '25$1.7MMar '26$2.7MJun '26

Diluted EPS by quarter

-0.26Dec '24-0.08Mar '25-0.08Jun '25-0.04Sep '25-0.38Dec '250.02Mar '260.03Jun '26

Free cash flow by quarter

$19.4MDec '24$-15.0MMar '25$-2.5MJun '25$-1.8MSep '25$12.9MDec '25$-2.4MMar '26$22.5MJun '26

Annual revenue

$935.9MFY23$948.9MFY24$1.0BFY25

Profitability & balance sheet

Gross margin14.9%
Operating margin1.4%
Net margin-2.7%
Return on equity-4.5%
Return on assets-1.5%
Return on invested capital1.7%
Current ratio1.44
Liabilities / assets66.0%
Cash & investments$69.71M
Total debt$948.82M
Net cash (debt)-$879.12M
Free cash flow / sales3.0%

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Outpatient$196.21M 73.1%
  • Professional$72.25M 26.9%

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Net Change in Cash $18.48M -$7.60M $32.70M $58.64M -$4.55M
Beginning Cash Balance $51.23M $58.83M $26.13M $191,000.00 $4.75M
Free Cash Flow $22.53M -$2.38M -$6.40M $12.85M -$1.77M
Gain/Loss from Continuing Operations $576,000.00 $2.81M -$2.72M $5.42M -$8.96M
-Change in Other Current Assets -$2.03M -$4.35M -$13.30M $3.21M -$3.78M
-Change in Payables and Accrued Expense $20.92M -$21.44M -$3.52M $2.37M $3.91M
-Change in Prepaid Assets $1.46M $1.57M -$6.28M $410,000.00 $341,000.00
Deferred Tax $2.09M $726,000.00 $8.08M $4.57M $2.03M
-Change in Receivables -$18.09M -$3.28M -$14.01M -$1.50M $1.80M
Change in Working Capital -$711,000.00 -$28.86M -$44.35M -$852,000.00 -$686,000.00
Other Non-Cash Items $1.28M $384,000.00 $6.18M $1.84M $1.28M
Depreciation & Depletion & Amortization $14.08M $13.88M $55.39M $16.24M $13.39M
Net cash flow from continuing operations $32.80M $2.93M $17.07M $17.10M $11.86M
Net Income from Continuing Operations $2.75M $1.72M -$47.10M -$28.69M -$3.50M
Operating Cash Flow $32.80M $2.93M $17.07M $17.10M $11.86M
-Change in Other Current Liabilities -$2.99M -$1.37M -$7.24M -$5.34M -$2.95M
Financing Cash Flow -$685,000.00 -$5.26M $36.58M $43.93M -$2.75M
Net cash flow from investing -$13.64M -$5.27M -$20.96M -$2.40M -$13.67M
Net Cash Flow from Continuing Investing Activities -$13.64M -$5.27M -$20.96M -$2.40M -$13.67M
Net PPE Purchase and Sale -$9.67M -$5.27M -$20.83M -$2.40M -$13.55M
Ending Cash Balance $69.71M $51.23M $58.83M $58.83M $191,000.00
Net Cash Flow from Continuing Financing Activities -$685,000.00 -$5.26M $36.58M $43.93M -$2.75M
Net Issuance Payments Of Debt -$199,000.00 -$5.26M -$381.92M -$373.74M -$2.87M
Net Common Stock Issuance -$332,000.00 $0.00 $435.59M $434.75M $120,000.00
Net Business Purchase and Sale – – -$123,000.00 $0.00 -$123,000.00
Net Other Financing Charges – – -$17.08M – –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
-Other Payable $2.32M $3.85M $3.91M $3.91M $2.88M
-Total Tax Payable $4.23M $535,000.00 $421,000.00 $421,000.00 $10.94M
-Accounts Payable $27.06M $37.17M $44.86M $44.86M $35.19M
Payables $33.61M $41.55M $49.19M $49.19M $49.01M
Total Current Liabilities $178.36M $157.93M $179.19M $179.19M $179.99M
Total Liabilities $1.19B $1.16B $1.18B $1.18B $1.52B
-Other Intangible Assets $39.72M $40.25M $41.34M $41.34M $42.87M
-Goodwill $807.55M $807.55M $807.55M $807.55M $807.55M
Goodwill and Other Intangible Assets $847.28M $847.80M $848.89M $848.89M $850.42M
-Long Term Equity Investment $423.33M $420.52M $423.19M $423.19M $424.55M
Investments and Advances $423.33M $420.52M $423.19M $423.19M $424.55M
-Gross PPE $233.10M $226.30M $500.82M $500.82M $206.98M
Net PPE $233.10M $226.30M $221.26M $221.26M $206.98M
Current Accrued Expenses $52.69M $44.24M $41.87M $41.87M $42.68M
Short-Term Debt and Capital Lease Obligation $42.13M $40.59M $38.78M $38.78M $43.72M
-Current Debt $15.60M $15.13M $14.71M $14.71M $22.17M
Retained Earnings -$626.60M -$629.34M -$631.06M -$631.06M -$602.37M
Additional Paid-In Capital $1.24B $1.23B $1.22B $1.22B –
-Common Stock $96,000.00 $96,000.00 $96,000.00 $96,000.00 $769.48M
Capital Stock $96,000.00 $96,000.00 $96,000.00 $96,000.00 $769.48M
Stockholders' Equity $615.06M $599.62M $586.12M $586.12M $167.11M
Total Equity $615.06M $599.62M $586.12M $586.12M $167.11M
Other Non-Current Liabilities $38.54M $37.44M $34.74M $34.74M $36.31M
Non-Current Deferred Liabilities $43.59M $41.50M $40.77M $40.77M $36.20M
-Long Term Capital Lease Obligation $113.47M $109.89M $104.70M $104.70M $90.66M
-Long Term Debt $819.75M $816.97M $819.03M $819.03M $1.18B
Long Term Debt and Capital Lease Obligation $933.23M $926.86M $923.73M $923.73M $1.27B
Total Non-Current Liabilities $1.02B $1.01B $999.24M $999.24M $1.34B
Total Non-Current Assets $1.55B $1.54B $1.54B $1.54B $1.52B
Prepaid Assets $14.50M $16.53M $17.58M $17.58M $17.08M
-Other Receivables $31.55M $20.05M $15.52M $15.52M $13.14M
-Accounts Receivable $140.66M $134.08M $131.84M $131.84M $135.51M
Receivables $172.21M $154.13M $150.85M $150.85M $148.65M
-Cash and Cash Equivalents $69.71M $51.23M $58.83M $58.83M $191,000.00
Cash and Cash Equivalents & Short-Term Investments $69.71M $51.23M $58.83M $58.83M $191,000.00
Total Current Assets $256.42M $221.89M $227.26M $227.26M $165.92M
Total Assets $1.81B $1.76B $1.76B $1.76B $1.69B
Other Non-Current Assets $48.65M $46.85M $43.95M $43.95M $41.99M
-Current Capital Lease Obligation $26.53M $25.46M $24.07M $24.07M $21.55M
-Accumulated Depreciation – – -$279.55M -$279.55M –
-Taxes Receivable – – $3.50M $3.50M –

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Diluted EPS $0.03 $0.02 -$0.66 -$0.38 -$0.04
Other Income (Expense) $17.59M $14.89M $59.59M $10.23M $17.37M
Non-Operating Interest Expense $16.22M $16.33M $118.54M $28.02M $30.58M
Net Non-Operating Interest Income (Expense) -$16.22M -$16.33M -$118.54M -$28.02M -$30.58M
Operating Profit $4.40M $4.53M $26.73M -$7.47M $12.97M
-Depreciation & Amortization $10.08M $9.92M $40.38M $12.40M $9.65M
Depreciation & Amortization & Depletion $10.08M $9.92M $40.38M $12.40M $9.65M
-General & Admin Expense $24.40M $20.34M $90.45M $37.19M $17.08M
Selling and Admin Expenses $24.40M $20.34M $90.45M $37.19M $17.08M
Operating Expense $34.48M $30.26M $130.83M $49.59M $26.74M
Gross Profit $38.88M $34.78M $157.57M $42.12M $39.71M
Cost of Revenue $225.29M $217.76M $865.52M $225.62M $219.24M
Total Operating Revenue $264.16M $252.54M $1.02B $267.73M $258.94M
Total Revenue as Reported $264.16M $252.54M $1.02B $267.73M $258.94M
Earnings from Equity Interest $18.62M $15.02M $72.14M $22.30M $17.99M
Special Income (Charges) -$1.03M -$137,000.00 -$14.42M -$13.94M -$623,000.00
-Less:Other Special Charges $1.05M – $13.45M – –
Basic EPS $0.03 $0.02 -$0.66 -$0.38 -$0.04
Net Income to Common Stockholders $2.75M $1.72M -$47.10M -$28.69M -$3.50M
Profit from Continuing Operations $2.75M $1.72M -$47.10M -$28.69M -$3.50M
Net Profit $2.75M $1.72M -$47.10M -$28.69M -$3.50M
Tax $3.02M $1.36M $14.89M $3.43M $3.26M
Pretax Profit $5.77M $3.08M -$32.22M -$25.26M -$237,000.00
-Gain on Sale of Property/Plant/Equipment $24,000.00 -$137,000.00 -$968,000.00 -$491,000.00 -$623,000.00
Net Income to Parent Company $2.75M $1.72M -$47.10M -$28.69M -$3.50M
-Less:Impairment of Capital Assets – – $0.00 – –
Other Non-Operating Income (Expenses) – – $1.87M – –

Discussion

No comments yet — be the first to weigh in on LMRI.

Leave a comment

Scroll to Top